Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Sesn2em1/Cya
Common Name:
Sesn2-KO
Product ID:
S-KO-06375
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Sesn2-KO
Strain ID
KOCMP-230784-Sesn2-B6N-VA
Gene Name
Sesn2
Product ID
S-KO-06375
Gene Alias
HI95; SEST2; Ses2
Background
C57BL/6NCya
NCBI ID
230784
Modification
Conventional knockout
Chromosome
4
Phenotype
MGI:2651874
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Sesn2em1/Cya mice (Catalog S-KO-06375) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000030724
NCBI RefSeq
NM_144907
Target Region
Exon 2~6
Size of Effective Region
~4.7 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Sesn2, also known as Sestrin2, is a stress-inducible protein and a powerful anti-oxidant [1]. It is transcriptionally activated by stress factors like metabolic derangements, reactive oxygen species (ROS), and DNA-damage. One of its well-known functions is the inhibition of the mechanistic target of rapamycin complex 1 kinase (mTORC1), which is crucial for cell growth and autophagy regulation. It also has mTORC1-independent activities related to mitochondrial function and cell death regulation. Sesn2 is involved in multiple biological processes, such as oxidative stress response, cell viability control, and mitochondrial homeostasis, and is thus of great biological importance. Genetic models, like KO/CKO mouse models, can help in further understanding its functions.

In Sesn2-deficient mice, defective mitophagy was observed, leading to hyperactivation of inflammasomes and increased mortality in sepsis models, indicating Sesn2's role in suppressing sepsis by inducing mitophagy and inhibiting NLRP3 activation in macrophages [3]. In high-fat diet-induced obese mice, obesity decreased Sesn2 expression in adriamycin-exposed hearts. Overexpression of Sesn2 blocked the destructive cascades and cardiac oxidative damage effects induced by high-fat diet/sodium palmitate combined with adriamycin, suggesting it could be a therapeutic target for improving anthracycline-related cardiotoxicity in obesity [2]. In addition, knockdown of Sesn2 in mdx mice, an animal model of Duchenne muscular dystrophy (DMD), led to decreased Myogenin (Myog) expression and increased Pax7 expression, while its overexpression enhanced the proportion of slow-switch myofibers, indicating its role in promoting myogenic differentiation and skeletal muscle regeneration [4]. In genetic defective mice of Sesn2 (Sesn2-/-), dendritic cells (DCs) exhibited exacerbated ferroptosis, suggesting Sesn2 can suppress DC ferroptosis in sepsis by down-regulating the ATF4-CHOP-CHAC1 signaling pathway [5]. Knockdown of Sesn2 in denervated mouse gastrocnemius muscles aggravated atrophy, while Sesn2 induction protected against atrophy through the unfolded protein response and mitophagy [6].

In conclusion, Sesn2 is essential for multiple biological functions, including anti-oxidative stress, regulation of mitochondrial function, and cell growth. Through KO/CKO mouse models, its roles in various disease conditions such as sepsis, anthracycline-related cardiotoxicity, DMD, sepsis-induced ferroptosis, and denervated muscle atrophy have been revealed. These findings contribute to understanding the underlying mechanisms of these diseases and may provide potential therapeutic targets.

References:

1. Wang B, Jie, Wang, Shudong, Xiao, Mengjie, Tang, Yufeng, Gu, Junlian. 2020. Regulatory mechanisms of Sesn2 and its role in multi-organ diseases. In Pharmacological research, 164, 105331. doi:10.1016/j.phrs.2020.105331. https://pubmed.ncbi.nlm.nih.gov/33285232/

2. Gao, Ting, Wang, Jie, Xiao, Mengjie, Li, Jiahao, Gu, Junlian. 2023. SESN2-Mediated AKT/GSK-3β/NRF2 Activation to Ameliorate Adriamycin Cardiotoxicity in High-Fat Diet-Induced Obese Mice. In Antioxidants & redox signaling, 40, 598-615. doi:10.1089/ars.2022.0156. https://pubmed.ncbi.nlm.nih.gov/37265150/

3. Kim, Min-Ji, Bae, Soo Han, Ryu, Jae-Chan, Ryu, Ji-Hwan, Yoon, Joo-Heon. 2016. SESN2/sestrin2 suppresses sepsis by inducing mitophagy and inhibiting NLRP3 activation in macrophages. In Autophagy, 12, 1272-91. doi:10.1080/15548627.2016.1183081. https://pubmed.ncbi.nlm.nih.gov/27337507/

4. Song, Zubiao, Lin, Qing, Liang, Jiahui, Zhang, Weixi. 2024. Inhibition of Sesn2 has negative regulatory effects on the myogenic differentiation of C2C12 myoblasts. In Molecular biomedicine, 5, 31. doi:10.1186/s43556-024-00193-z. https://pubmed.ncbi.nlm.nih.gov/39117956/

5. Li, Jing-Yan, Ren, Chao, Wang, Li-Xue, Tian, Ying-Ping, Yao, Yong-Ming. 2021. Sestrin2 protects dendrite cells against ferroptosis induced by sepsis. In Cell death & disease, 12, 834. doi:10.1038/s41419-021-04122-8. https://pubmed.ncbi.nlm.nih.gov/34482365/

6. Yang, Xiaofan, Xue, Pingping, Yuan, Meng, Machens, Hans-Günther, Chen, Zhenbing. 2021. SESN2 protects against denervated muscle atrophy through unfolded protein response and mitophagy. In Cell death & disease, 12, 805. doi:10.1038/s41419-021-04094-9. https://pubmed.ncbi.nlm.nih.gov/34429398/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest